Sweden· SE-20210316000012
Teglutik 5 mg/ml Oral suspension
A medicinal product containing riluzole, registered in Sweden by Italfarmaco S.A..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Riluzole
- Manufacturer
- Italfarmaco S.A.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20210316000012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Riluzole in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTeglutik 5 mg/mlItalfarmaco
- SwitzerlandTeglutik 50mg/10ml, suspension buvableEFFIK SA
- SpainTEGLUTIK 5MG/ML SUSPENSION ORALItalfarmaco S.A.
- FinlandTeglutikItalfarmaco SA
- FranceTEGLUTIK 5 mg/ml, suspension buvableITALFARMACO (ESPAGNE)
- NetherlandsTeglutik 5 mg/ml, suspensie voor oraal gebruikItalfarmaco, S.A.
- NorwayTeglutikItalfarmaco S.A.
- United StatesTIGLUTIKItalfarmaco SPA
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Emylif, Riluzol Aristo
- Belgium · Emylif, Riluzol Ab
- Cyprus · Teglutik
- Czechia · Riluzol Pmcs
- Germany · Emylif, Glentek
- Denmark · Emylif, Glentek
- Estonia · Lizolorol, Rilustad
- Spain · Emylif, Riluzol Aurovitas
- Finland · Teglutik
- France · Emylif, Riluzole Arrow
- United Kingdom (Northern Ireland) · Emylif, Riluzole Accord Healthcare
- Greece · Teglutik
- Croatia · Alsemol
- Hungary · Sclefic
- Iceland · Emylif, Rilutek
- Italy · Emylif, Riluzolo Aurobindo
- Liechtenstein · Rilutek, Riluzole Zentiva
- Luxembourg · Emylif, Teglutik
- Netherlands · Emylif, Glentek
- Norway · Emylif, Rilutek
- Poland · Riluzol Pmcs, Riluzole Sun
- Portugal · Emylif, Riluzol Aurovitas
- Romania · Riluzol Pmcs
- Slovenia · Sclefic
- Slovakia · Riluzol Pmcs
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5830a9c2-a37a-4100-baaf-0a7d9300193d GET /v1/drugs/5830a9c2-a37a-4100-baaf-0a7d9300193d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20210316000012",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20210316000012",
"product_doc_link": "https://docetp.mpa.se/LMF/Teglutik%20oral%20suspension%20SmPC_09001bee824d376d.pdf"
}See everything about riluzole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.